-transparent.png){kind=logo}
Twenty-two patients with idiopathic thrombocytopenic purpura were treated with high-dose intravenous immunoglobulin infusions using an intact intravenous immunoglobulin preparation and a product designed for intramuscular administration. Seventeen patients (77%) responded favourably (rise in platelet count to 100 X 10(9)/1 or above). Children responded better than the adults, and the acute cases better than the chronic. Splenectomy and the presence of detectable platelet antibody had no effect on the response rate. Both products induced identical responses.
Related Publications
H I Atrah, and
R J Crawford, and
G S Gabra, and
R Mitchell
May 1987,
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
H I Atrah, and
R J Crawford, and
G S Gabra, and
R Mitchell
November 1989,
Postgraduate medicine,
H I Atrah, and
R J Crawford, and
G S Gabra, and
R Mitchell
January 1986,
Progress in hemostasis and thrombosis,
H I Atrah, and
R J Crawford, and
G S Gabra, and
R Mitchell
January 1984,
The American journal of pediatric hematology/oncology,
H I Atrah, and
R J Crawford, and
G S Gabra, and
R Mitchell
July 1987,
European journal of haematology,
H I Atrah, and
R J Crawford, and
G S Gabra, and
R Mitchell
March 1989,
Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
H I Atrah, and
R J Crawford, and
G S Gabra, and
R Mitchell
September 1987,
Hematology/oncology clinics of North America,
H I Atrah, and
R J Crawford, and
G S Gabra, and
R Mitchell
January 1989,
International reviews of immunology,
H I Atrah, and
R J Crawford, and
G S Gabra, and
R Mitchell
April 2005,
Human immunology,
H I Atrah, and
R J Crawford, and
G S Gabra, and
R Mitchell
January 1993,
Vox sanguinis,
